logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

NivolumabType 1 diabetes mellitus, hypothyroidism and thyrotoxicosis: 2 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2020年 / 1795卷 / 1期
关键词:
D O I:
10.1007/s40278-020-76228-1
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:207 / 207
相关论文
共 50 条
  • [1] Atezolizumab/nivolumabType 1 diabetes mellitus: 2 case reports
    Reactions Weekly, 2018, 1688 (1) : 35 - 35
  • [2] NivolumabType 1 diabetes mellitus and adrenal insufficiency: 2 case reports
    Reactions Weekly, 2020, 1785 (1) : 396 - 396
  • [3] Ipilimumab/nivolumabType 1 diabetes mellitus, pancreatic injury and autoimmune thyroiditis: 2 case reports
    Reactions Weekly, 2020, 1788 (1) : 136 - 136
  • [4] NivolumabType 1 diabetes mellitus: case report
    Reactions Weekly, 2020, 1787 (1) : 398 - 398
  • [5] NivolumabType 1 diabetes mellitus: case report
    Reactions Weekly, 2020, 1792 (1) : 177 - 177
  • [6] NivolumabType-1 diabetes mellitus: case report
    Reactions Weekly, 2021, 1837 (1) : 532 - 532
  • [7] Ipilimumab/nivolumabType 1 diabetes mellitus: case report
    Reactions Weekly, 2024, 2037 (1) : 221 - 221
  • [8] NivolumabType-1-diabetes-mellitus: case report
    Reactions Weekly, 2020, 1809 (1) : 191 - 191
  • [9] NivolumabType-1 diabetes mellitus: case report
    Reactions Weekly, 2019, 1753 (1) : 261 - 261
  • [10] NivolumabType-1 diabetes mellitus: case report
    Reactions Weekly, 2019, 1748 (1) : 385 - 385
← 12345 →